» Articles » PMID: 22523501

Immunolocalization of NLRP3 Inflammasome in Normal Murine Airway Epithelium and Changes Following Induction of Ovalbumin-Induced Airway Inflammation

Abstract

Little is known about innate immunity and components of inflammasomes in airway epithelium. This study evaluated immunohistological evidence for NLRP3 inflammasomes in normal and inflamed murine (Balb/c) airway epithelium in a model of ovalbumin (OVA) induced allergic airway inflammation. The airway epithelium of control mice exhibited strong cytoplasmic staining for total caspase-1, ASC, and NLRP3, whereas the OVA mice exhibited strong staining for active caspase-1, with redistribution of caspase-1, IL-1β and IL-18, indicating possible activation of the NLRP3 inflammasome. Active caspase-1, NLRP3, and other inflammasome components were also detected in tissue eosinophils from OVA mice, and may potentially contribute to IL-1β and IL-18 production. In whole lung, inRNA expression of NAIP and procaspase-1 was increased in OVA mice, whereas NLRP3, IL-1β and IL-18 decreased. Some OVA-treated mice also had significantly elevated and tightly correlated serum levels of IL-1β and TNFα. In cultured normal human bronchial epithelial cells, LPS priming resulted in a significant increase in NLRP3 and II-lp protein expression. This study is the first to demonstrate NLRP3 inflammasome components in normal airway epithelium and changes with inflammation. We propose activation and/or luminal release of the inflammasome is a feature of allergic airway inflammation which may contribute to disease pathogenesis.

Citing Articles

NR1D1 deficiency in the tumor microenvironment promotes lung tumor development by activating the NLRP3 inflammasome.

Kim S, Jeon Y, Jang J, Lee H Cell Death Discov. 2023; 9(1):278.

PMID: 37524704 PMC: 10390518. DOI: 10.1038/s41420-023-01554-3.


Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways.

Dubyak G, Miller B, Pearlman E Immunol Rev. 2023; 314(1):229-249.

PMID: 36656082 PMC: 10407921. DOI: 10.1111/imr.13186.


Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Kotlyarov S Int J Mol Sci. 2022; 23(2).

PMID: 35055174 PMC: 8778852. DOI: 10.3390/ijms23020985.


Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke.

Asare P, Tran H, Hurtado P, Perkins G, Nguyen P, Jersmann H Ther Adv Respir Dis. 2021; 15:17534666211039769.

PMID: 34852704 PMC: 8647217. DOI: 10.1177/17534666211039769.


Carbon Monoxide as a Therapeutic for Airway Diseases: Contrast and Comparison of Various CO Delivery Modalities.

Tripathi R, Yang X, Ryter S, Wang B Curr Top Med Chem. 2021; 21(32):2890-2908.

PMID: 34784868 PMC: 9206592. DOI: 10.2174/1568026621666211116090917.


References
1.
Broide D, Lotz M, Cuomo A, Coburn D, Federman E, Wasserman S . Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992; 89(5):958-67. DOI: 10.1016/0091-6749(92)90218-q. View

2.
Eder C . Mechanisms of interleukin-1beta release. Immunobiology. 2009; 214(7):543-53. DOI: 10.1016/j.imbio.2008.11.007. View

3.
Schroder N . The role of innate immunity in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2008; 9(1):38-43. DOI: 10.1097/ACI.0b013e32831d0f99. View

4.
Pizzirani C, Ferrari D, Chiozzi P, Adinolfi E, Sandona D, Savaglio E . Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood. 2006; 109(9):3856-64. DOI: 10.1182/blood-2005-06-031377. View

5.
Tsukagoshi H, Sakamoto T, Xu W, Barnes P, Chung K . Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J Allergy Clin Immunol. 1994; 93(2):464-9. DOI: 10.1016/0091-6749(94)90355-7. View